Standout Papers

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1... 2011 2026 2016 2021 443
  1. Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG) (2011)
    Ignace Vergote, Elizabeth A. Eisenhauer et al. International Journal of Gynecological Cancer
  2. Enhancing the rate of genetic gain in public-sector plant breeding programs: lessons from the breeder’s equation (2019)
    Joshua N. Cobb, P. Biswas et al. Theoretical and Applied Genetics

Immediate Impact

6 by Nobel laureates 8 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
5 intermediate papers

Works of Michael Quinn being referenced

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics
1999
Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening
1995
and 2 more

Author Peers

Author Last Decade Papers Cites
Michael Quinn 3130 2162 2540 3626 2956 335 12.4k
Robert P. Edwards 2611 2672 2080 3787 2067 306 11.6k
Yong Sang Song 3080 2846 2303 2297 4136 405 11.5k
Jae‐Weon Kim 4972 4867 2316 3006 3659 554 13.9k
Carolyn D. Runowicz 2342 1434 2015 5714 2478 169 12.5k
Clemens Tempfer 2513 1895 1064 1899 1841 366 8.9k
Nobuo Yaegashi 4234 4247 2146 1605 3409 638 13.6k
Ulf‐Håkan Stenman 2606 1387 1254 4010 5436 606 19.8k
Rainer Kimmig 3489 1790 619 3537 2202 395 10.0k
David R. Spriggs 2045 771 929 4808 4177 229 12.8k
Matthias W. Beckmann 2500 2569 715 3738 3516 635 14.8k

All Works

Loading papers...

Rankless by CCL
2026